News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
HORIZONS-AMI: No Additional Stent Thrombosis At One Year With Paclitaxel-Eluting Stent
March 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cardiology Today -- Rates of stent thrombosis at one year were similar in patients taking bivalirudin compared with those taking glycoprotein IIb/IIIa inhibitors, results from an analysis suggested.
Twitter
LinkedIn
Facebook
Email
Print